======= TBX5 ======= == Gene Information == * **Official Symbol**: TBX5 * **Official Name**: T-box transcription factor 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6910|6910]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q99593|Q99593]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TBX5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TBX5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601620|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene is closely linked to related family member T-box 3 (ulnar mammary syndrome) on human chromosome 12. The encoded protein may play a role in heart development and specification of limb identity. Mutations in this gene have been associated with Holt-Oram syndrome, a developmental disorder affecting the heart and upper limbs. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: DNA-binding protein that regulates the transcription of several genes and is involved in heart development and limb pattern formation (PubMed:25725155, PubMed:25963046, PubMed:29174768, PubMed:26917986, PubMed:27035640, PubMed:8988164). Binds to the core DNA motif of NPPA promoter (PubMed:26926761). {ECO:0000269|PubMed:25725155, ECO:0000269|PubMed:25963046, ECO:0000269|PubMed:26917986, ECO:0000269|PubMed:26926761, ECO:0000269|PubMed:27035640, ECO:0000269|PubMed:29174768, ECO:0000269|PubMed:8988164}. |T-box| |cell migration involved in coronary vasculogenesis| |cardiac left ventricle formation| |cell migration involved in vasculogenesis| |positive regulation of secondary heart field cardioblast proliferation| |bundle of His development| |vasculogenesis involved in coronary vascular morphogenesis| |His-Purkinje system development| |positive regulation of cardioblast differentiation| |regulation of cardioblast differentiation| |regulation of secondary heart field cardioblast proliferation| |cardiac ventricle formation| |regulation of cardioblast proliferation| |cardiac chamber formation| |cardiac conduction system development| |negative regulation of cardiac muscle cell proliferation| |cell migration involved in heart development| |cardiac left ventricle morphogenesis| |atrial septum morphogenesis| |coronary vasculature morphogenesis| |regulation of cell proliferation involved in heart morphogenesis| |pericardium development| |atrial septum development| |positive regulation of stem cell differentiation| |negative regulation of cardiac muscle tissue growth| |negative regulation of heart growth| |atrioventricular valve morphogenesis| |positive regulation of cardiac muscle cell proliferation| |atrioventricular valve development| |negative regulation of epithelial to mesenchymal transition| |positive regulation of cardiocyte differentiation| |cardiac atrium morphogenesis| |negative regulation of organ growth| |negative regulation of cardiac muscle tissue development| |positive regulation of cardiac muscle tissue growth| |embryonic forelimb morphogenesis| |cardiac atrium development| |regulation of animal organ formation| |positive regulation of heart growth| |regulation of cardiac muscle cell proliferation| |regulation of heart morphogenesis| |forelimb morphogenesis| |endocardial cushion development| |positive regulation of cardiac muscle tissue development| |protein-DNA complex| |coronary vasculature development| |negative regulation of striated muscle tissue development| |positive regulation of organ growth| |negative regulation of muscle organ development| |regulation of cardiocyte differentiation| |negative regulation of muscle tissue development| |heart valve morphogenesis| |RNA polymerase II activating transcription factor binding| |ventricular cardiac muscle tissue development| |regulation of cardiac muscle tissue growth| |heart valve development| |regulation of heart growth| |vasculogenesis| |positive regulation of striated muscle tissue development| |positive regulation of muscle organ development| |positive regulation of muscle tissue development| |ventricular septum development| |cardiac septum morphogenesis| |cardiac ventricle morphogenesis| |regulation of cardiac muscle tissue development| |regulation of epithelial to mesenchymal transition| |cell fate specification| |cardiac muscle cell differentiation| |regulation of organ growth| |negative regulation of developmental growth| |cardiac septum development| |cardiocyte differentiation| |regulation of stem cell differentiation| |embryonic appendage morphogenesis| |embryonic limb morphogenesis| |cardiac chamber morphogenesis| |cardiac ventricle development| |regulation of striated muscle tissue development| |regulation of muscle tissue development| |regulation of muscle organ development| |limb morphogenesis| |appendage morphogenesis| |cardiac muscle tissue development| |lung development| |cardiac chamber development| |positive regulation of developmental growth| |respiratory tube development| |transcription initiation from RNA polymerase II promoter| |limb development| |appendage development| |respiratory system development| |striated muscle cell differentiation| |DNA-templated transcription, initiation| |mesenchyme development| |negative regulation of growth| |muscle cell differentiation| |cell fate commitment| |heart morphogenesis| |regulation of animal organ morphogenesis| |positive regulation of growth| |negative regulation of cell migration| |negative regulation of cell motility| |striated muscle tissue development| |muscle tissue development| |negative regulation of cellular component movement| |RNA polymerase II regulatory region sequence-specific DNA binding| |negative regulation of locomotion| |regulation of developmental growth| |transcription factor binding| |blood vessel morphogenesis| |sequence-specific DNA binding| |morphogenesis of an epithelium| |pattern specification process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |muscle structure development| |transcription by RNA polymerase II| |blood vessel development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |vasculature development| |cardiovascular system development| |heart development| |tissue morphogenesis| |embryonic morphogenesis| |protein-containing complex| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |tube morphogenesis| |regulation of growth| |DNA-binding transcription factor activity| |negative regulation of cell population proliferation| |negative regulation of cell differentiation| |tube development| |regulation of cell migration| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |anatomical structure formation involved in morphogenesis| |regulation of cell motility| |positive regulation of cell population proliferation| |negative regulation of developmental process| |animal organ morphogenesis| |cell migration| |positive regulation of cell differentiation| |embryo development| |regulation of locomotion| |regulation of cellular component movement| |regulation of anatomical structure morphogenesis| |cell motility| |localization of cell| |nucleobase-containing compound biosynthetic process| |epithelium development| |cell-cell signaling| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |locomotion| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |movement of cell or subcellular component| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of cell population proliferation| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |macromolecule biosynthetic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|1.93| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11236 * **Expression level (log2 read counts)**: -2.28 {{:chemogenomics:nalm6 dist.png?nolink |}}